Skip to Content

Introduction to Clinical Oncology


Introductory video transcript:
English | Español | Português | 中文

Course Overview

The Introduction to Clinical Oncology course provides an overview of the key foundational concepts in cancer care and is taught by faculty and other cancer professionals at The University of Texas MD Anderson Cancer Center. The course is intended for physicians, physician assistants, advanced practice nurses, clinical pharmacists, and other health care professionals as well as students, residents, and fellows. The course covers cancer prevention and risk assessment, diagnosis and screening of hematological and solid tumors, and various treatment modalities, including surgery, radiation therapy, and drug treatment. Additional lectures are provided on oncologic emergencies, symptom management, palliative care, and survivorship care.

     Course Overview: Español  |  Português  |  中文

 

Accreditation/Credit Designation

The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this enduring material for a maximum of 9.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

The Palliative Care Lecture, Parts I, II and III, has been designated by The University of Texas MD Anderson Cancer Center for 1.00 AMA PRA Category 1 Credit™ in medical ethics and/or professional responsibility.

 

Lectures


Clinical Trials   Top of Page
 
Presenter: Diane Bodurka, M.D.
Professor
Department of Gynecologic Oncology and Reproductive Medicine
 

Summary: Dr. Diane Bodurka, the Vice President for Medical Education and a professor in the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center, presents a lecture on clinical research in oncology. Various phases of clinical trials and endpoints for cancer clinical trials are discussed. Ethical principles specific to clinical research are discussed, including methods to ensure ethical treatment of patients participating in clinical trials.

     Summary and Learning Objectives: Español

Patrick Lynch, M.D.
Cancer Risk Factors   Top of Page
 
Presenter: Patrick Lynch, M.D.
Professor, Department of Gastroenterology
Hepatology and Nutrition
 

Summary: Dr. Patrick Lynch, a professor in the Department of Gastroenterology, Hepatology and Nutrition at The University of Texas MD Anderson Cancer Center, discusses the risk factors for malignancy including environmental, occupational, infectious, and biological factors. Dr. Lynch also emphasizes the impact of family history on cancer risk and provides other important examples of factors affecting the risk of common malignancies including breast, colon, endometrial, ovarian, cervical, lung, and thyroid cancers and melanoma.

     Summary and Learning Objectives: Español  |  Português  |  中文


Cancer Genetic Risk Assessment   Top of Page
 
Presenter: Maureen Mork, M.S., CGC
Genetic Counselor
Department of Clinical Cancer Genetics

Summary: Ms. Maureen Mork, a certified genetic counselor in the Department of Cancer Genetics at The University of Texas MD Anderson Cancer Center, presents this lecture on “Cancer Genetic Risk Assessment,” for cancer patients and their families. This presentation reviews red flags in patient histories that suggest possible hereditary cancers. Ms. Mork reviews the process of genetic counseling. She also describes the benefits, limitations and risks of genetic testing for hereditary cancer.

     Summary and Learning Objectives: Español

Sally Scroggs, MS, RD, LD  Cancer Prevention   Top of Page
 
Presenter: Sally Scroggs, MS, RD, LD
Manager, Health Education Cancer Prevention Center
 
Presenter: Therese B. Bevers, M.D.
Professor, Department of Clinical Cancer Prevention

Summary: Ms. Sally Scroggs, a licensed dietician and the Manager of Health Education in the Department of Clinical Cancer Prevention, and Dr. Therese Bevers, a Professor in the Department of Clinical Cancer Prevention and Medical Director of the Cancer Prevention Center at The University of Texas MD Anderson Cancer Center, provide this two part presentation on cancer prevention. In Part 1 of this lecture series, Ms. Scroggs introduces cancer risk assessment and discusses health promotion and lifestyle and diet modification strategies for reducing cancer risk in the general population. In Part 2, Dr. Bevers discusses surgical interventions for breast, ovarian, and colorectal cancers and describes chemoprevention strategies for preventing the development of cancer in patients at an increased risk of the disease.

     Summary and Learning Objectives Part 1: Español
     Summary and Learning Objectives Part 2: Español


Screening for Cancer   Top of Page
 
Presenter: Therese B. Bevers, M.D.
Professor
Department of Clinical Cancer Prevention
 

Summary: Dr. Therese Bevers, a professor in the Department of Clinical Cancer Prevention and the Medical Director of the Cancer Prevention Center at The University of Texas MD Anderson Cancer Center, provides this presentation on cancer screening. Dr. Bevers describes the characteristics of patient populations that are appropriate for screening, discusses the evidence supporting current screening recommendations, and contrasts screening tests with diagnostic tests. Dr. Bevers also defines common terms that are used to evaluate the efficacy of screening tests and provides reliable sources of cancer screening guidelines.

     Summary and Learning Objectives: Español

Maura Polansky, MS, PA-C
Solid Tumors: Diagnosis and Staging   Top of Page
 
Presenter: Maura Polansky, MS, MHPE, PA-C
Program Director
Physician Assistant Education
 

Summary: Ms. Maura Polansky, Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director of Physician Assistant Education at The University of Texas MD Anderson Cancer Center, provides this lecture on the diagnosis and staging of solid tumors. Ms. Polansky discusses the process involved in making an initial diagnosis of various types of solid tumors, introduces the TNM staging system, and details the parameters involved in assessing the primary tumor, regional lymph node involvement, and distant metastasis. Ms. Polansky also describes various imaging studies used to diagnose and stage solid tumors.

     Summary and Learning Objectives: Español  |  Português  |  中文

Tapan Kadia, M.D. Jorge Romaguera, M.D. Hematologic Malignancies: Diagnosing and Staging   Top of Page
 
Presenter: Tapan Kadia, M.D.
Assistant Professor, Department of Leukemia
 
Presenter: Jorge Romaguera, M.D.
Professor, Department of Lymphoma/Myeloma

Summary: Dr. Tapan Kadia, an assistant professor in the Department of Leukemia and Dr. Jorge Romaguera, a professor in the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center, present lectures on the Diagnosis and Staging of Hematologic Malignancies. In Part 1 of his lecture, Dr. Kadia reviews the normal hematologic and lymphatic systems and describes the role of each hematologic cell type. Dr. Kadia also defines cytopenia; discusses the presentation, diagnosis, and staging of leukemias and myelodysplastic syndromes; and describes the similarities and differences between myelodysplastic syndrome and acute myeloid leukemia. In Part 2, Dr. Romaguera introduces lymphomas and compares and contrasts Hodgkin's lymphoma, Non-Hodgkin's lymphoma, and multiple myeloma. Dr. Romaguera also discusses the clinical presentation of these diseases as well as the hematologic, radiographic, and pathologic findings used to classify and stage each.

     Summary and Learning Objectives Part 1: Español
     Summary and Learning Objectives Part 2: Español

Barry Feig, M.D.
Treatment Modalities: Surgery   Top of Page
 
Presenter: Barry Feig, M.D.
Professor
Department of Surgical Oncology
 

Summary: Dr. Barry Feig, a professor in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center, discusses the role of surgery in solid tumors and hematologic malignancies. Dr. Feig explains the various types of biopsies used in diagnosing cancer, the role of surgery in the treatment and palliation of cancer, and the complications sometimes encountered after surgery.

     Summary and Learning Objectives: Español  |  Português  |  中文

Prajnan Das, M.D., M.P.H.
Treatment Modalities: Radiation Therapy   Top of Page
 
Presenter: Prajnan Das, M.D., M.P.H.
Assistant Professor
Department of Radiation Oncology
 

Summary: Dr. Prajnan Das, an associate professor in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center, reviews the basic principles of radiation therapy and its role in the treatment of malignancy. Dr. Das defines the key concepts and common terminology associated with radiation therapy. Treatment planning and delivery are considered, as well as the roles of, and indications for, radiation therapy in the management of cancer. Acute and late effects are also discussed.

     Summary and Learning Objectives: Español  |  Português  |  中文

Hillary Prescott, Pharm.D., BCOP Jeff Bryan, Pharm.D. Treatment Modalities: Drug Therapy   Top of Page
 
Presenter: Hillary Prescott, Pharm.D., BCOP
Clinical Pharmacy Specialist, Division of Pharmacy
 
Presenter: Jeff Bryan, Pharm.D.
Clinical Pharmacy Specialist, Division of Pharmacy

Summary: Dr. Hillary Prescott and Dr. Jeffrey Bryan, Clinical Pharmacy Specialists in the Department of Clinical Pharmacy Programs at The University of Texas MD Anderson Cancer Center, provide this two part presentation on the role of drug therapy as a treatment modality for cancer. In Part 1 of this lecture, Dr. Prescott discusses the goals and various roles of drug therapy in the treatment of patients with solid tumors and hematologic malignancies. Dr. Prescott introduces the classes of chemotherapeutic agents and how chemotherapy and hormone therapy differ. In Part 2, Dr. Bryan discusses several types of immune-based and targeted therapies and reviews the common toxicities of various drugs and the factors that influence drug toxicity.

     Summary and Learning Objectives: Español  |  Português  |  中文


Treatment Modalities: Stem Cell Transplants   Top of Page
 
Presenter: Megan Cornelison, M.S., PA-C
Physician Assistant
Department of Stem Cell Transplantation
 

Summary: Ms. Megan Cornelison, a physician assistant in the Department of Stem Cell Transplantation at The University of Texas MD Anderson Cancer Center, reviews the role of stem cell transplantation for the treatment of malignancies. She discusses the methods of obtaining and transplanting stem cells, distinguishing among autologous, allogenic, and umbilical cord sources for stem cells. Indications for stem cell transplantation are reviewed, as are post-transplantation complications, with an emphasis on graft-versus-host disease.

     Summary and Learning Objectives: Español

John Patlan, M.D
Oncologic Emergencies   Top of Page
 
Presenter: John Patlan, M.D.
Associate Professor, Department of General Internal Medicine
Ambulatory Treatment and Emergency Care
 

Summary: Dr. John Patlan, an associate professor in the Department of General Internal Medicine at The University of Texas MD Anderson Cancer Center, presents this lecture on oncologic emergencies. Dr. Patlan discusses the diagnosis and treatment of common structural emergencies associated with cancer and anticancer treatment, like spinal cord compression and SVC syndrome. He advises how to manage patients with neutropenic fever, as well as diagnose and treat metabolic emergencies, including hypercalcemia, and tumor lysis syndrome.

     Summary and Learning Objectives: Español

Cynthia Abarado, MS, RN, GNP-BC
Supportive Management   Top of Page
 
Presenter: Cynthia Abarado, MS, RN, GNP-BC.
Advanced Practice Nurse
Department of Genitourinary Medical Oncology
 

Summary: Ms. Cynthia Abarado, an advanced practice nurse in the Department of Genitourinary Medical Oncology at The University of Texas MD Anderson Cancer Center, presents this lecture on supportive management of cancer-related symptoms. Ms. Abarado identifies common cancer-related symptoms and reviews the process of assessing cancer patients for the presence and severity of such symptoms. She also discusses the management of and therapeutic interventions for cancer-related pain, fatigue, and malnutrition. The side effects of opioids, including constipation, nausea, and sedation, are also discussed.

     Summary and Learning Objectives (Cancer-related Symptoms): Español
     Summary and Learning Objectives (Treatment-related Effects): Español

Donna Zhukovsky, M.D.
Palliative Care   Top of Page
 
Presenter: Donna S. Zhukovsky, M.D.
Professor
Department of Palliative Care and Rehabilitation Medicine
 

Summary: Dr. Donna Zhukovsky, a professor in the Department of Palliative Care and Rehabilitation Medicine at The University of Texas MD Anderson Cancer Center, presents a three part lecture series on palliative care for cancer patients. In Part 1 of this lecture, Dr. Zhukovsky introduces and defines palliative care, emphasizing the symptoms that patients with advanced cancer commonly experience, and discusses clinical approaches to assessing and managing such symptoms. In Part 2, Dr. Zhukovsky discusses advance care planning, defines different advance directives used to support advance care planning, and notes the similarities and differences among medical powers of attorney, living wills, and out-of-hospital DNR orders. She also provides a framework for discussing end-of-life care issues with patients and their families. In Part 3, Dr. Zhukovsky describes models of palliative care in the United States and introduces hospice care. In addition, Dr. Zhukovsky describes the key differences between home care and hospice care and explains the requirement for hospice admission criteria.

     Summary and Learning Objectives: Español

Alma Rodriguez, M.D., F.A.C.P.
Cancer Survivorship   Top of Page
 
Presenter: Alma Rodriguez, M.D., F.A.C.P.
Vice President, Medical Affairs
Professor, Department of Lymphoma/Myeloma
 

Summary: Dr. Alma Rodriguez, the Vice President of Medical Affairs and professor in the Department of Lymphoma and Myeloma at The University of Texas MD Anderson Cancer Center, provides this lecture on cancer survivorship. In this lesson, she defines cancer survivorship and discusses the expanding population of cancer survivors. A variety of common sequelae of cancer therapy are discussed as well as other issues facing cancer survivors, including cancer surveillance, risk of second primary cancers, and psychosocial and economic concerns. The MD Anderson Survivorship Passport is introduced, and the importance of primary care providers in providing survivorship care is emphasized.

     Summary and Learning Objectives: Español  |  Português  |  中文

 

 

For further information or assistance, to provide feedback on this web site, or to request a specific professional oncology education topic, please e-mail Professional Oncology Education.

Course Options


© 2014 The University of Texas MD Anderson Cancer Center